7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 
                         
      cash flows from operating activities
    		                     
      net loss
    		6,139,000 -8,029,000 -353,000 -20,037,000 4,262,000 -4,863,000 -6,392,000 -44,361,000 20,875,000 -19,065,000 -22,120,000 -32,980,000 -30,297,000 -39,605,000 -37,037,000 -34,244,000 -21,668,000 -12,221,000 -8,544,000 -14,201,000 -10,855,000 
      adjustments to reconcile net loss to net cash from operating activities:
    		                     
      depreciation and amortization expense
    		-1,120,000 -436,000 4,281,000 10,327,000 -28,000                 
      amortization of discount on convertible notes
    		2,000 -22,000 187,000                   
      amortization of premium on convertible notes
    		-6,000 -6,000 -402,000                   
      stock-based compensation expense
    		-909,000 2,027,000 5,209,000 25,218,000 150,000 1,621,000 8,388,000               
      provision for expected credit losses
    		-1,827,000 668,000 930,000 1,919,000 439,000 -13,000 863,000 852,000              
      real estate and internal-use software charges
    		                     
      gain on lease modification
    		   0                  
      gain on convertible notes extinguishment
    		  -3,931,000                   
      changes in operating assets and liabilities:
    		                     
      accounts receivable
    		12,745,000 -12,025,000 3,020,000 -14,651,000 7,235,000 -4,202,000 -2,588,000 -4,278,000 2,161,000 6,425,000 -8,185,000 -5,072,000 -5,764,000 -6,999,000 -2,502,000 -7,381,000 -2,188,000 -3,811,000 -3,899,000 -1,832,000 -1,468,000 
      prepaid expenses and other assets
    		-5,518,000 7,243,000 -5,084,000                   
      deferred commissions
    		411,000 -1,188,000 1,935,000 566,000 791,000 -613,000 211,000 -1,126,000 -230,000 -821,000 49,000 -949,000 -459,000 -1,397,000 -658,000 -1,441,000 -631,000 -657,000 -796,000 -942,000 -690,000 
      accounts payable
    		568,000 -234,000 678,000 -1,917,000 1,378,000 533,000 -889,000 1,182,000 308,000 -1,023,000 495,000 -204,000 935,000 -1,642,000 -287,000 2,326,000 187,000 754,000 -1,130,000 222,000 -186,000 
      accrued and other liabilities
    		-9,850,000 16,215,000 -8,137,000 3,078,000 -4,403,000 8,769,000 -4,601,000 1,022,000 -28,963,000 7,027,000 -4,922,000  -28,638,000 15,550,000 5,702,000  8,436,000     
      deferred revenue
    		-3,639,000 5,012,000 2,068,000 10,413,000 -3,672,000 5,039,000 2,568,000 9,442,000 -6,296,000 6,292,000 3,123,000 2,211,000 653,000 2,427,000 14,000 -280,000 45,000 -357,000 1,989,000 -255,000 652,000 
      net cash from operating activities
    		-3,004,000 13,156,000 401,000 20,681,000 -6,165,000 15,155,000 -3,417,000 7,186,000 -25,336,000 14,743,000 -20,836,000 -2,693,000 -50,804,000 -13,875,000 -21,985,000 -8,817,000 -14,077,000 -4,648,000 -12,758,000 -3,329,000 -6,206,000 
      capital expenditures
    		-1,316,000 -826,000 -825,000 0 0 -258,000 -806,000 -3,124,000 1,025,000 -1,017,000 -1,063,000 -990,000 -720,000 -2,146,000 -1,340,000 -1,017,000 -643,000 -1,164,000 -480,000 -586,000 -333,000 
      free cash flows
    		-4,320,000 12,330,000 -424,000 20,681,000 -6,165,000 14,897,000 -4,223,000 4,062,000 -24,311,000 13,726,000 -21,899,000 -3,683,000 -51,524,000 -16,021,000 -23,325,000 -9,834,000 -14,720,000 -5,812,000 -13,238,000 -3,915,000 -6,539,000 
      cash flows from investing activities:
    		                     
      cash paid for website domain name
    		  -2,444,000                   
      cash paid for acquisition
    		           0 0   -115,000      
      purchase of property, equipment, leasehold improvements and capitalized internal-use software
    		-1,316,000 -826,000 -825,000                   
      maturity of marketable securities
    		27,500,000 -15,579,000 28,579,000 129,640,000 -2,855,000 33,085,000 29,440,000 160,032,000   39,429,000 38,900,000 22,050,000 33,600,000 9,000,000       
      purchase of marketable securities
    		-11,757,000 -24,627,000 -7,945,000 -30,841,000 -48,318,000 34,528,000 -35,565,000 -172,600,000 77,713,000 -85,351,000 -48,043,000 -44,297,000 -90,614,000 -46,800,000 -32,473,000 -63,539,000 -13,070,000 -12,023,000 -18,374,000   
      net cash from investing activities
    		14,427,000 -38,588,000 17,365,000 96,042,000 -51,073,000 67,255,000 -6,931,000 -23,583,000 38,801,000 -2,725,000 -9,677,000 -6,387,000 -69,284,000 -16,042,000 -24,813,000 -60,171,000 -94,665,000 -13,187,000 -18,854,000 -586,000 -333,000 
      cash flows from financing activities:
    		                     
      proceeds from exercise of stock options
    		-1,533,000 877,000 1,096,000 1,470,000 -33,000 -703,000 974,000 2,394,000 -790,000    172,000 -292,000 184,000  1,371,000 1,127,000 1,741,000  1,051,000 
      taxes paid related to net share settlement of stock options
    		-424,000 1,099,000 -1,225,000 -1,363,000   -1,325,000 -2,255,000              
      payment of convertible note issuance costs
    		  -217,000 -656,000                  
      repayment of convertible notes and financing obligation
    		  -54,528,000 -410,000                  
      net cash from financing activities
    		-1,957,000 56,721,000 -54,874,000 -1,959,000 -112,211,000 619,000 -485,000 957,000 -811,000 1,426,000 -330,000 145,000 172,000 -292,000 184,000 1,642,000 300,764,000 1,127,000 1,741,000 44,543,000 160,007,000 
      net change in cash and cash equivalents and restricted cash
    		9,466,000 31,289,000 -37,108,000 114,764,000 -169,449,000 83,029,000 -10,833,000 -15,440,000 12,654,000 13,444,000 -30,843,000 -8,935,000 -119,916,000 -30,209,000 -46,614,000 -67,346,000 192,022,000 -16,708,000 -29,871,000 40,628,000 153,468,000 
      cash and cash equivalents and restricted cash, beginning of period
    		-5,819,000 -37,108,000 90,356,000 -61,363,000 72,196,000 -10,833,000 72,845,000 17,399,000 -17,399,000 0 93,030,000 0 0 0 298,704,000 0 0 0 220,607,000 0 0 
      cash and cash equivalents and restricted cash, end of period
    		3,647,000 -5,819,000 53,248,000 53,401,000 -97,253,000 72,196,000 62,012,000 1,959,000 -4,745,000 13,444,000 62,187,000 -8,935,000 -119,916,000 -30,209,000 252,090,000 -67,346,000 192,022,000 -16,708,000 190,736,000 40,628,000 153,468,000 
      supplemental cash flow information:
    		                     
      cash paid for interest
    		  5,685,000 448,000 2,012,000 -433,000 439,000 452,000 11,000 0 431,000 0 431,000 0 472,000     766,000  
      cash paid for taxes
    		-175,000 39,000 220,000 288,000 51,000 -98,000 140,000 454,000 -83,000 60,000 152,000 0 0 0 32,000       
      noncash investing and financing activities:
    		                     
      capital additions, accrued but not paid
    		70,000 530,000 205,000  -11,000                 
      fair value of shares issued as consideration for acquisition
    		           768,000 6,000         
      right-of-use asset obtained in exchange for new operating lease liability
    		  5,516,000                   
      principal amount of 2028 convertible notes exchanged
    		   0                  
      other
    		                     
      amortization of discount on convertible note
    		   1,238,000                  
      amortization of premium on convertible note
    		                     
      gain on convertible note extinguishment
    		   0                  
      holdback payments related to business combination
    		                     
      proceeds from financing obligation
    		                     
      changes in capital additions, accrued but not paid
    		       -56,000 34,000 125,000 65,000  2,000 9,000 96,000       
      fair value of shares issued as consideration for business combinations
    		                     
      amortization of convertible note premium
    		                     
      impairment loss
    		                     
      prepaid expenses
    		    -1,894,000 8,895,000 -4,960,000 4,150,000 1,397,000 751,000 -4,235,000 2,817,000 -4,961,000 1,816,000 -806,000 4,094,000 -6,915,000 990,000 -582,000 971,000 -1,422,000 
      purchase of property and equipment
    		    0 -258,000 -806,000 -3,124,000 1,025,000 -1,017,000 -1,063,000 -990,000 -720,000 -2,146,000 -1,340,000 -1,017,000 -643,000 -1,164,000 -480,000 -586,000 -333,000 
      amortization of discount on debt
    		     0 497,000 1,482,000 -493,000 494,000 493,000 492,000 490,000 490,000 488,000 487,000    294,000 91,000 
      repayment of debt
    		     -3,000 -134,000 -263,000            -21,902,000 -474,000 
      depreciation and amortization
    		      3,486,000 9,343,000 -2,707,000 2,940,000 2,904,000 2,791,000 2,983,000 2,821,000 2,826,000 2,630,000 2,084,000 731,000 706,000 707,000 699,000 
      impairment of right-of-use assets
    		                     
      cash paid for business combinations
    		                     
      payment of debt issuance costs
    		               0      
      purchase of capped calls
    		               0      
      proceeds from debt
    		                   0 1,116,000 
      reconciliation of cash, cash equivalents and restricted cash within the consolidated balance sheet to the amounts shown in the statements of cash flows above:
    		                     
      cash and cash equivalents
    		       1,940,000 -4,738,000 13,447,000 61,070,000 -9,036,000 -119,941,000 -30,384,000 250,934,000 -67,348,000 192,037,000 -16,706,000 189,578,000   
      restricted cash
    		       19,000 -7,000 -3,000 1,117,000 101,000 25,000 175,000 1,156,000 2,000 -15,000 -2,000 1,158,000   
      total cash, cash equivalents and restricted cash
    		       1,959,000 -4,745,000 13,444,000 62,187,000 -8,935,000 -119,916,000 -30,209,000 252,090,000 -67,346,000 192,022,000 -16,708,000 190,736,000   
      stock-based compensation
    		        -10,004,000 11,290,000 10,487,000 12,146,000 10,646,000 10,578,000 8,962,000 7,742,000 5,989,000 6,522,000 5,171,000 6,020,000 2,868,000 
      other noncash expenses
    		                     
      reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheet to the amounts shown in the statements of cash flows above:
    		                     
      allowance for credit losses
    		         433,000 1,075,000 1,237,000 3,608,000 2,086,000 1,313,000 1,350,000 497,000 901,000 726,000  254,000 
      sales and maturities of marketable securities
    		                     
      taxes paid related to net share settlement of equity awards
    		                     
      net payment of settlement of equity-based awards
    		          -330,000           
      change in fair value of financial instrument
    		                   0 0 
      restructuring charges
    		                     
      accrued and other current liabilities
    		                  -6,399,000 5,291,000 3,851,000 
      proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other offering costs
    		                   1,000  
      proceeds from issuance of common stock upon secondary offering, net of underwriting discounts and commissions and other offerings costs
    		                     
      payment of series f dividends
    		                     
      proceeds from exercise of stock options and warrants
    		                     
      proceeds from issuance of convertible senior notes
    		                     
      conversion of convertible preferred stock into common stock upon initial public offering
    		                   0  
      conversion of convertible debt into common stock upon initial public offering
    		                   0  
      proceeds from the issuance of convertible senior notes
    		                     
      non-cash investing and financing activities:
    		                     
      accretion on discount to marketable securities
    		                     
      payment of dividends
    		                     
      issuance of warrants
    		                     
      reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheet to the amounts show in the statements of cash flows above:
    		                     
      cash flows from operating activities:
    		                     
      proceeds from issuance of convertible preferred stock, net of issuance costs
    		                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.